Accéder au contenu
Merck

Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses.

The Journal of physiology (2016-07-28)
Karin R Aubrey, Geoffrey M Drew, Hyo-Jin Jeong, Benjamin K Lau, Christopher W Vaughan
RÉSUMÉ

The midbrain periaqueductal grey (PAG) forms part of an endogenous analgesic system which is tightly regulated by the neurotransmitter GABA. The role of endocannabinoids in regulating GABAergic control of this system was examined in rat PAG slices. Under basal conditions GABAergic neurotransmission onto PAG output neurons was multivesicular. Activation of the endocannabinoid system reduced GABAergic inhibition by reducing the probability of release and by shifting release to a univesicular mode. Blockade of endocannabinoid system unmasked a tonic control over the probability and mode of GABA release. These findings provides a mechanistic foundation for the control of the PAG analgesic system by disinhibition. The midbrain periaqueductal grey (PAG) has a crucial role in coordinating endogenous analgesic responses to physiological and psychological stressors. Endocannabinoids are thought to mediate a form of stress-induced analgesia within the PAG by relieving GABAergic inhibition of output neurons, a process known as disinhibition. This disinhibition is thought to be achieved by a presynaptic reduction in GABA release probability. We examined whether other mechanisms have a role in endocannabinoid modulation of GABAergic synaptic transmission within the rat PAG. The group I mGluR agonist DHPG ((R,S)-3,5-dihydroxyphenylglycine) inhibited evoked IPSCs and increased their paired pulse ratio in normal external Ca

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Picrotoxin, powder
Sigma-Aldrich
DL-Propargylglycine, cystathionine γ-lyase inhibitor
Sigma-Aldrich
CNQX, ≥98% (HPLC), solid
Sigma-Aldrich
Strychnine hydrochloride
Sigma-Aldrich
JZL195, ≥98% (HPLC)